HCPCS Section
Drugs administered other than oral method, chemotherapy drugs

J7607 is a valid 2026 HCPCS code meaning Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg or (Levalbuterol comp con) for short. HCPCS J7607 has been effective since 01/01/2007 and applies to Medical care.

---

See also

• HCPCS J7606 · Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms

• HCPCS J7612 · Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg

• HCPCS J7614 · Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg

• HCPCS J7615 · Levalbuterol, inhalation solution, compounded product, administered through dme, unit dose, 0.5 mg

• HCPCS J7608 · Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram

¹ Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

² BETOS stands for “Berenson-Eggers Type Of Service”

---

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026

CPT^® is a registered trademark of the American Medical Association (AMA). All rights reserved.